105 related articles for article (PubMed ID: 8093104)
1. The effects of two acylcoenzyme A: cholesterol acyltransferase (ACAT) inhibitors, cyclandelate and a non-hydrolysable ether analogue, benzyl3,3,5-trimethylcyclohexanol on low density lipoprotein metabolism in macrophages and hepatocytes.
White DA; Heffron F; Knight D; Salter AM
Biochem Pharmacol; 1994 Aug; 48(5):915-22. PubMed ID: 8093104
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of acyl coenzyme A: cholesterol acyl transferase by trimethylcyclohexanylmandelate (cyclandelate).
Heffron F; Middleton B; White DA
Biochem Pharmacol; 1990 Feb; 39(3):575-80. PubMed ID: 2306268
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of cholesterol esterification by cyclandelate in transformed mouse macrophages.
Heffron F; Middleton B; White DA
Biochem Pharmacol; 1993 May; 45(9):1829-34. PubMed ID: 8494541
[TBL] [Abstract][Full Text] [Related]
4. Cyclandelate. An inhibitor of cholesterol esterification.
Middleton B; Cacciaguerra F; White D
Drugs; 1987; 33 Suppl 2():75-9. PubMed ID: 3622309
[TBL] [Abstract][Full Text] [Related]
5. Chemical synthesis of dual-radiolabelled cyclandelate and its metabolism in rat hepatocytes and mouse J774 cells.
White DA; Heffron F; Miciak A; Middleton B; Knights S; Knight D
Xenobiotica; 1990 Jan; 20(1):71-9. PubMed ID: 2327109
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cellular cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblasts.
Middleton B
Biochem Biophys Res Commun; 1987 May; 145(1):350-6. PubMed ID: 3593342
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
[TBL] [Abstract][Full Text] [Related]
9. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
10. Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver.
Salter AM; Hayashi R; al-Seeni M; Brown NF; Bruce J; Sorensen O; Atkinson EA; Middleton B; Bleackley RC; Brindley DN
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):825-32. PubMed ID: 2064617
[TBL] [Abstract][Full Text] [Related]
11. Foam cell-forming J774 macrophages have markedly elevated acyl coenzyme A:cholesterol acyl transferase activity compared with mouse peritoneal macrophages in the presence of low density lipoprotein (LDL) despite similar LDL receptor activity.
Tabas I; Boykow GC; Tall AR
J Clin Invest; 1987 Feb; 79(2):418-26. PubMed ID: 3805276
[TBL] [Abstract][Full Text] [Related]
12. N-[2-[N'-pentyl-(6,6-dimethyl-2,4-heptadiynyl)amino]ethyl]- (2-methyl-1-naphthylthio)acetamide (FY-087). A new acyl coenzyme a:cholesterol acyltransferase (ACAT) inhibitor of diet-induced atherosclerosis formation in mice.
Nagata Y; Yonemoto M; Iwasawa Y; Shimizu-Nagumo A; Hattori H; Sawazaki Y; Kamei T
Biochem Pharmacol; 1995 Mar; 49(5):643-51. PubMed ID: 7887979
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages.
Shige H; Ishikawa T; Suzukawa M; Nishiwaki M; Yamashita T; Nakajima K; Ito T; Higashi K; Ayaori M; Yonemura A; Nestel P; Nakamura H
Lipids; 1998 Dec; 33(12):1169-75. PubMed ID: 9930402
[TBL] [Abstract][Full Text] [Related]
14. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and high-density lipoprotein-induced cholesterol efflux in macrophages.
Azuma Y; Kawasaki T; Ikemoto K; Ohno K; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1999 Feb; 79(2):159-67. PubMed ID: 10202851
[TBL] [Abstract][Full Text] [Related]
15. Exposure of rat peritoneal macrophages to acetylated low density lipoprotein results in release of plasma membrane cholesterol. An efficient substrate for esterification by acyl-CoA:cholesterol acyltransferase.
Shinohara M; Miyazaki A; Shichiri M; Morino Y; Horiuchi S
J Biol Chem; 1992 Jan; 267(3):1603-8. PubMed ID: 1730705
[TBL] [Abstract][Full Text] [Related]
16. Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level.
Xu XX; Tabas I
J Biol Chem; 1991 Sep; 266(26):17040-8. PubMed ID: 1894601
[TBL] [Abstract][Full Text] [Related]
17. Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein.
Tabas I; Boykow GC
J Biol Chem; 1987 Sep; 262(25):12175-81. PubMed ID: 3624250
[TBL] [Abstract][Full Text] [Related]
18. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
[TBL] [Abstract][Full Text] [Related]
19. A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal.
Umeda Y; Hirano T; Kako Y; Kamagata K; Okuyama K; Suzuki K
Life Sci; 1998; 63(13):PL187-95. PubMed ID: 9763214
[TBL] [Abstract][Full Text] [Related]
20. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
